A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia
Số trang: 13
Loại file: pdf
Dung lượng: 1.48 MB
Lượt xem: 17
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The real-world experience of Swiss chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) is largely unknown, in particular with regard to achievement of response per European Leukemia Net (ELN) criteria and adherence to ELN recommendations.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Chronic myeloid leukemia Deep molecular response Real-world evidence Tyrosine kinase inhibitorsTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 173 0 0 -
6 trang 167 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 144 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 121 0 0 -
12 trang 94 0 0
-
19 trang 75 0 0
-
17 trang 65 0 0
-
9 trang 45 0 0
-
Expression of deubiquitinase genes and inflammatory response in Myeloid leukemia
8 trang 39 0 0 -
12 trang 39 0 0